Alaterre, E., Goldschmidt, H., Seckinger, A., & Hose, D. (2017). CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma. OncoTarget, 8(58), . https://doi.org/10.18632/oncotarget.22131
Chicago Style (17th ed.) CitationAlaterre, Elina, Hartmut Goldschmidt, Anja Seckinger, and Dirk Hose. "CD24, CD27, CD36 and CD302 Gene Expression for Outcome Prediction in Patients with Multiple Myeloma." OncoTarget 8, no. 58 (2017). https://doi.org/10.18632/oncotarget.22131.
MLA (9th ed.) CitationAlaterre, Elina, et al. "CD24, CD27, CD36 and CD302 Gene Expression for Outcome Prediction in Patients with Multiple Myeloma." OncoTarget, vol. 8, no. 58, 2017, https://doi.org/10.18632/oncotarget.22131.
Warning: These citations may not always be 100% accurate.